United States · Bill · S
S. 1324 (94th)
A bill to amend the Federal Food, Drug, and Cosmetic Act, as amended, to prohibit the use of any name in connection with any prescription drug other than the official name designated or such drug by the Secretary of Health, Education, and Welfare.
Introduced
24 March 1975
Last action
—
Status
Referred to Senate Committee on Labor and Public Welfare.
Sponsors
—
Subjects
Discovery layer
Source updated
21 April 2025
Summary
Directs the Secretary of Health, Education, and Welfare to designate an official name for any new drug subject to prescription sale and for all drugs presently subject to such sale, within one year after the date of enactment of this Act. Provides that drugs labeled or advertised by any name other than the official name shall be deemed to be misbranded. Authorizes the Secretary to exempt drugs from carrying the official name for one year in order to avoid confusion or to permit the orderly transition to revised labeling. Requires that drug labels be printed in type which is conspicuous.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Introduced in Senate
summary · EN · 24 March 1975
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/94th-congress/senate-bill/1324
- Open data entity: https://api.congress.gov/v3/bill/94/s/1324